Pursuant to 21 CFR 1301.33(a), this is notice that on April 29, 2004, Syva Company, Dade Behring Inc., Regulatory Affairs Dept #1-310, 20400 Mariani Avenue, Cupertino, California 95014, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below, and by letter dated July 6, 2004, to modify its name to Dade Behring, Inc.
| Drug | Schedule |
|---|---|
| Tetrahydrocannabionols (7370) | I |
| Ecgonine (9180) | II |
| Morphine (9300) | II |
The company plans to produce bulk products used for the manufacture of reagents and drug calibrator/controls, DEA exempt products.
Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCD) and must be filed no later than October 12, 2004.
Dated: July 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 04-18181 Filed 8-9-04; 8:45 am]
BILLING CODE 4410-01-M